Compare GRFS & ANF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GRFS | ANF |
|---|---|---|
| Founded | 1940 | 1892 |
| Country | Spain | United States |
| Employees | 25247 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Clothing/Shoe/Accessory Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 4.4B |
| IPO Year | N/A | 1996 |
| Metric | GRFS | ANF |
|---|---|---|
| Price | $8.27 | $84.53 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 12 |
| Target Price | $10.15 | ★ $120.50 |
| AVG Volume (30 Days) | 573.0K | ★ 945.8K |
| Earning Date | 07-28-2022 | 05-27-2026 |
| Dividend Yield | ★ 1.80% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 10.46 |
| Revenue | N/A | ★ $5,266,292,000.00 |
| Revenue This Year | $4.49 | $5.10 |
| Revenue Next Year | $6.42 | $3.83 |
| P/E Ratio | $18.67 | ★ $8.09 |
| Revenue Growth | N/A | ★ 6.42 |
| 52 Week Low | $7.08 | $65.45 |
| 52 Week High | $11.14 | $133.11 |
| Indicator | GRFS | ANF |
|---|---|---|
| Relative Strength Index (RSI) | 50.07 | 38.31 |
| Support Level | $7.64 | $82.80 |
| Resistance Level | $8.88 | $101.34 |
| Average True Range (ATR) | 0.18 | 3.57 |
| MACD | -0.02 | -1.14 |
| Stochastic Oscillator | 38.54 | 9.64 |
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.
Abercrombie & Fitch Co is a digitally led, omnichannel retailer offering apparel, personal care products, and accessories for men, women, and kids through company-owned stores, digital channels, and third-party arrangements. The company operates through three geographic segments: Americas, the maximum revenue generator; Europe, the Middle East and Africa (EMEA); and Asia-Pacific (APAC). Its brand families include Abercrombie brands and Hollister brands. The Americas segment covers North and South America, EMEA includes Europe, the Middle East and Africa, and APAC includes the Asia-Pacific region, including Asia and Oceania.